MOUNTAIN VIEW, Calif., July 03, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. IGMS today announced the closing of its previously announced upsized underwritten public offering of 1,597,827 shares of its voting common stock and 9,000,000 shares of its non-voting common stock and including the full exercise of the underwriters’ option…Read More
IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters Option to Purchase Additional Shares IGM Biosciences NASDAQIGMS
